Followers | 39 |
Posts | 9514 |
Boards Moderated | 0 |
Alias Born | 05/12/2006 |
Saturday, April 15, 2017 9:01:35 PM
12:01
ADAPTIR™ BISPECIFICS, A NOVEL PLATFORM FOR DEVELOPMENT OF IMMUNO-ONCOLOGY THERAPEUTICS
Key features and differentiating aspects of the ADAPTIR™ bispecific platform, including new preclinical in vivo and in vitro activity, pharmacokinetic and manufacturability data. ADAPTIR™ bispecific proteins offer advantages over other formats, derived from the flexible and modular nature of the ADAPTIR™ structure. Potent biological activity can be achieved, while retaining traditional antibody-like manufacturing characteristics. One ADAPTIR™ molecule is currently undergoing clinical trials, with several more bispecific immunotherapies in preclinical development.
Mr David Bienvenue, Director of Protein Sciences, Aptevo Therapeutics
- See more at: http://www.terrapinn.com/conference/americas-antibody-congress/Agenda-Day-2.stm#sthash.ySCX3fN9.dpuf
Recent APVO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 12:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 12:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 01:56:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:05:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:12:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:07:18 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 01:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:15:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:37:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 11:04:47 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 01/30/2024 01:00:01 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 01/16/2024 09:15:01 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/22/2023 09:15:04 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/12/2023 09:19:01 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/01/2023 05:15:15 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/22/2023 09:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:17:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2023 08:10:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2023 08:07:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2023 12:44:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/10/2023 12:41:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 12:30:35 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM